Friday 29 th, October 2010



Similar documents
1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

GOLNIK 17/06/10 COURSE ON LUNG CANCER AND MESOTHELIOMA June 2010 Golnik, Slovenia. Chair: T. Cufer, SI - G.L. Ceresoli, IT

Lung Cancer and Pleural Mesothelioma: Cleveland Clinic Multidisciplinary Approaches to Care

ELCC 2015 Industry Satellite Symposium The Treatment Roadmap for Squamous NSCLC. Thursday 16th April :10 14:20 Room C

2015 Feb.4th. AROME Radiobiology Course and Innovations: from biology to clinical practice of hypo fractionation and Stereotactic Radiotherapy

WORKSHOP IN LUNG CANCER CLINICAL RESEARCH Improving opportunities in the LATAM region

PERSONALIZED CANCER TREATMENT A multidisciplinary event

Advances in Lung Cancer: A Multidisciplinary Approach

British Thoracic Oncology Group (BTOG) Annual Report - April 2014 to March 2015

REPORT ASCO 2002 ORLANDO : LUNG CANCER Johan F. Vansteenkiste, MD, PhD, Univ. Hospital and Leuven Lung Cancer Group

Friday April 8 th 2016

Best of San Antonio Breast Cancer Symposium

GIORGIO VITTORIO SCAGLIOTTI, M.D. CURRICULUM VITAE

The 3 rd Clinical Research Training Course

CLINICAL ONCOLOGY MASTERCLASS IN April 2015 São Paulo, Brazil. Chairs: Scientific Co-ordinators: ESO - LATIN-AMERICAN PROGRAMME

2nd International Symposium on Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

Treatment Algorithms for the Management of Lung Cancer in NSW Guide for Clinicians

SAKK Lung Cancer Group. Current activities and future projects

We look forward to both your participation and contribution to this meeting.

Brigham and Women s Hospital, Boston, MA, USA; 2 Verastem, Inc., Boston, MA, USA

Summary of treatment benefits

How treatment is planned Giving your consent The benefits and disadvantages of treatment Second opinion

ONCOLOGY NURSING 7 TH ESO-EONS MASTERCLASS IN March 2014 Ermatingen (Lake Constance) Switzerland MASTERCLASS

OPEN Regional Meeting June 26 and June 27, 2015 Hyatt Regency Pier Sixty Six 2301 Southeast 17th Street Fort Lauderdale, Florida, AGENDA

International Conference on Medical Rehabilitation and Prevention of Blindness. November 27 th 29 th, 2015 TENTATIVE SCIENTIFIC PROGRAM

The European Haemophilia Consortium (EHC) brings patients and patient organisations together from 44 European countries.

Development of Evidence-Based Nursing in an Interdisciplinary Era: Achievements and Prospects

May 18, 2013 Sheraton Delfina Santa Monica, California

Lung Cancer in 2015: A Multidisciplinary Update

Regional Young Investigator SIC meeting. 5-6 March 2015

Cancerfondens planeringsgrupp för Onkologisk Nuklidterapi meeting November 2015

The New International Staging System Lung Cancer

Understanding the Molecular and Cellular Biology of Endocrine-Related Cancers. Mont Ste. Odile, Alsace, France September 2008

ASCO International Clinical Trials Workshop. May 7-8, Lazzoni Hotel Halic - Istanbul, Turkey

Transgene Presents Additional Positive Clinical Data from Phase 2b Part of TIME Trial with TG4010 at ESMO

ESSO Course on Peritoneal Surface Malignancy

Programme. Michele Grieco Dipartimento di Scienze Ambientali Seconda Università degli Studi di Napoli Naples, Italy

The 9th international conference of the International Mesothelioma Interest Group September Amsterdam, The Netherlands

Mesothelioma Paul Baas Department of Thoracic Oncology The Netherlands Cancer Institute Amsterdam

Avastin in breast cancer: Summary of clinical data

Report series: General cancer information

Malignant Mesothelioma State of the Art

L.N.Gumilyov Eurasian National University

WEDNESDAY 24 AUGUST 2011

Medical Education Department

International Symposium on Malignant Pleural Mesothelioma

KOL Insight: Non-small cell lung cancer Game changing immunotherapies to revolutionise treatment

Breast cancer research and a changing treatment pathway

Lung Cancer & Mesothelioma

AORTA MASTERCLASS 2015 Preliminary Programme

Final announcement Joint meeting in Radiation Biology and Radioecology

Big Data in Medicine

Amel Abd Allah Hashim Ahmed

Third International Conference of Faculty of Pharmacy Cairo University Entitled Good Pharmacy Practice

Cachexia and Nutrition in Advanced Cancer Patients: a Multidisciplinary Approach Chairs: M.S. Aapro, CH J. Herrstedt, DK F.

Book Public Health in the Arab World Editors: Samer Jabbour, Rita Giacaman, Marwan Khawaja, Iman Nuwayhid Associate Editor: Rouham Yamout

E UROPEAN PERSONAL INFORMATION

Eastern North Carolina Lung Cancer Symposium

Individualizing Your Lung Cancer Care: Informing Decisions Through Biomarker Testing

How To Prepare A Lung Cancer Screening Course

Global Non-Small Cell Lung Cancer Therapeutics Market

Word of Faculty Of Mass Communication, Cairo University

10 th EADO Congress Vilnius, 7-10 May Ipilimumab update. Michele Maio

International Symposium on Malignant Mesothelioma

Lung Cancer: More than meets the eye

ESMO 2014 Summary Breast Cancer

Lung cancer. A guide for journalists on Non-Small Cell Lung Cancer (NSCLC) and its treatment

Developments in Biomarker Identification and Validation for Lung Cancer

Male. Female. Death rates from lung cancer in USA

Scientific Committee Hilary Calvert UCL Cancer Institute, London, United Kingdom

May 21, 2011 Sheraton Delfina Santa Monica, California

FINAL AND PERMANENT VERSION THURSDAY, FEBRUARY 17, 2011 DAY 1 (FRIDAY, MAY 6, 2011): Chairpersons: E. Özer (TR) - S.A.Raptis (GR)

Treating Patients with Hormone Receptor Positive, HER2 Positive Operable or Locally Advanced Breast Cancer

How To Treat Mesothelioma With A Tumor Stem Cell Inhibitor

POLICY A. INDICATIONS

8 11 December 2011 Alexandria, Egypt

Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)

It s all about Europe s future with Cloud. EUROCLOUD FORUM th EuroCloud Congress Barcelona, October 7 9

Climate change adaptation for water, food and environment security

9 th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPD/C) 9th International Symposium

Investors' Access. Market. Strategic. Forum. Open. E-Health PROGRAM Alliance. Innovation PRELIMINARY. Management

Avastin in breast cancer: Summary of clinical data

I Module Crime Scene & Forensic Genetics

Lung cancer is not just one disease. There are two main types of lung cancer:

Please see the LUCADA data manual v3.1.3, available in the downloads section

Lung SSG 6 th May 2015 Research

Università degli studi di Genova DISEFIN DIPARTIMENTO DI SCIENZE ECONOMICHE E FINANZIARIE

Transcription:

Friday 29 th, October 2010 15:00-17:00 Registration 17:00-18:00 Opening Ceremony 18:00-18:30 Refreshment Break 18:30-19:00 Plenary Lecture I Nazli Gad El Mawla Memorial Lecture Chairpersons: Prof. Dr. M. El-Serafy, (NCI,Egypt) Prof. Dr. H. Khaled, (NCI,Egypt) Prof. Dr. H. Elzawahry, (NCI, Egypt) Prof. Dr. A. Abdel Warith, (NCI, Egypt) Prof. Dr. N. El-Lahlouby, (NCI, Egypt) 18:30-19:00 Molecular Targets for Breast Cancer: The Way to Personalized Therapy Prof. Dr. S. Murray, (MMOF - Greece) 19:00-21:00 Pharmaceutical Symposium NOVARTIS SYMPOSIUM (Breast Cancer) 21:30 Opening Ceremony Dinner

Saturday 30 th, October 2010 09:00-09:30 Plenary Lecture II Reda Hamza Memorial Lecture Chairpersons: Prof. Dr. A. Demirkazik, (MMOF, Turkey) Prof. Dr. A. Kandil, (Alexandria University, Egypt) Prof. Dr. Z. Khaled, (NCI, Egypt) Prof. Dr. A. El-Khodary, (NCI, Egypt) Prof. Dr. W.Elmetenawy, (NEMROCK, Egypt) 09:00-09:30 Non Small Cell Lung Cancer: Exploring New Avenues in Tailoring Cancer Treatment Prof. Dr. P. Kosmidis, (MMOF - Greece) 09:30-10:30 Satellite lecture ASTRA ZENECA 10:30-12:00 Session I Malignant Mesothelioma Chairpersons: Prof. Dr. M. Douzinas, (MMOF, Greece) Prof. Dr. A. Bahnassy, (NCI, Egypt) Prof. Dr. B. Hasan, (EORTC, Belgium) Prof. Dr. N. Mokhtar, (NCI, Egypt) Prof. Dr. R. Gaafar, (NCI, Egypt) Prof. Dr. K. Fragia, (MMOF, Greece) Prof. Dr S. El Khatib (KHCC, Jourdan) 10:30-10:45 Epidemiology of Mesothelioma in Egypt and Mediterranean countries Prof. Dr. N. Hassan, (NCI, Egypt) 10:45-11:00 Translational Research and Mesothelioma Prof. Dr. D. Fennell, (EORTC, Ireland) 11:00-11:15 Biomarkers in lung cancer and Mesothelioma Prof. Dr. M. El-Tanani, (Belfast, Ireland) 11:15-11:30 The extended debate of Surgery in Mesothelioma Prof. Dr. A. Abdel Rahman, (NCI, Egypt) 11:30-11:45 Novel agents for malignant mesothelioma Prof. Dr. B.Uluk, (MMOF, Turkey) 11:45-12:00 Discussion 12:00-12:15 Coffee Break 14:15-15:00 Lunch & Poster display 12:15-14:15 Pharmaceutical Symposium ROCHE SYMPOSIUM (Lung Cancer)

18:00-18:20 Coffee Breaks 15:00-16:00 Satellite lecture PIERRE FABRE 16:00-18:00 Pharmaceutical Symposium LILLY SYMPOSIUM 18:20-20:20 Session II Hot Topics and Challenges in Lung Cancer Chairpersons: Prof. Dr. B. Biesma, (EORTC, Netherlands) Prof. Dr. H. Elakkad, (Alexandria University, Egypt) Prof. Dr. V. Surmont, (EORTC, Belgium) Prof. Dr. I. Mourad, (NCI, Egypt) Prof. Dr. S. Abel Aziz, (NCI, Egypt) Prof. Dr. M. Helal, (NCI, Egypt) 18:20-18:40 State of art of surgery for NSCLC Prof. Dr. A. Maat, (EORTC, Netherlands) 18:40-19:00 Image guided therapy in lung cancer Prof. Dr. C. Fink, (EORTC, Germany) 19:00-19:20 Implementing Radiation and Systemic Therapy in Stage III NSCLC Prof. Dr. Y. Abdel Kader (NEMROCK, Egypt) 19:20-19:40 Open challenges in the treatment of advanced NSCLC Prof. Dr. R. Gaafar, (NCI, Egypt) 19:40-20:00 Advances in the treatment of SCLC Prof. Dr. M. O Brien, (EORTC, England) 20:00-20:20 Where do we stand in radiotherapy for SCLC? Prof. Dr. H. Abdel Baki, (NCI, Egypt) 20:20-21:00 Plenary Lecture III Highlights on Staging and Maintenance Therapy of NSCLC Chairpersons: Prof. Dr. M. Obrien, (EORTC, England) Prof. Dr. S. El-Mesidi, (NEMROCK, Egypt) Prof. Dr. S.Shamaa, (Mansoura University, Egypt) Prof. Dr. F. Abu Taleb, (Zagazig University, Egypt) Prof. Dr. A.Elkhodary, (NCI, Egypt) 20:20-20:40 Clinical Implications of the IASLC Revised Staging System Prof. Dr. J. VanMeerbeeck, (EORTC, Belgium) 20:40-21:00 Maintenance therapy in advanced NSCLC: Prof. Dr. E. Razis, (MMOF, Greece)

21:30 Gala Dinner Sunday 31 st, October 2010 09:00-10:00 Session III Hall (A) Keynote Lectures Chairpersons: Prof. Dr. P. Papakostas, (MMOF, Greece) Prof. Dr. G. Fountzilas, (MMOF, Greece) Prof. Dr. M. Saber, (NCI, Egypt) Prof. Dr. N. Eldib, (Alexandria University, Egypt) Prof. Dr. N. Anwar, (NCI, Egypt) 09:00-09:30 Breast cancer in Egypt: An overview Prof. Dr. H. Khaled, (NCI, Egypt) 09:30-10:00 Perspectives in the Biology and Management of Inflammatory Breast Cancer Prof.G. Basaran, (MMOF, Turkey) 10:00-11:00 Session IV Hall (A) Advances in Local Therapy for Early Breast Cancer Chairpersons: Prof. Dr. I. Yucel, (MMOF, Turkey) Prof. Dr. P. Skandalakis, (MMOF, Greece) Prof. Dr. S. Omar, (NCI, Egypt) Prof. Dr. S. Al Badawy, (NCI, Egypt) Prof. Dr. W. Yousry, (NCI, Egypt) Prof. Dr. M. Manieh, (NCI, Egypt) Prof. Dr. M. El Naggar, (NCI, Egypt) 10:00-10:20 Innovations in Breast Cancer Surgery Prof. Dr. E. Poulakaki, (MMOF, Greece) 10.20-10.40 Advances in Radiotherapy Prof. Dr. M. El Gentery, (NCI, Egypt) 10:40:11:00 Panel Discussion: Moderator: The Impact of Surgery and Radiotherapy on Quality Of Life in Young Women Prof. Dr Sami ElBadawy 11:00-11:30 Coffee Break

11:30-13:00 Session V Hall (A) Advances in Systemic Therapy for Early Breast Cancer Chairpersons: Prof. Dr S. Ismail (Ain Shams, Egypt) Prof. Dr. G. Asimakopoulos, (MMOF, Greece) Prof. Dr. D.Bafaloukos, (MMOF, Greece) Prof. Dr. H. Abdel Azim, (NEMROCK, Egypt) Prof. Dr. T. Hashem, (Menofia University, Egypt) Prof. Dr G.ElHosseiny (Alexandria, Egypt) 11:30-12:00 Controversies in Systemic Therapy of Early Breast Cancer Prof. Dr. N. El-Lahloubi, (NCI, Egypt) 12:00-12:30 Triple Negative Breast Cancer; A Special Entity Prof. Dr. S. Bavbek, (MMOF, Turkey) 12:30-13:00 Translational Research on New Molecular Markers An EORTC BCG Experience 13:00-14:00 Lunch & Poster display 14:00-16:00 Session VI Hall (A) Issues for Better Survival and Quality Of Life in Breast Cancer Chairpersons: Prof. Dr. O. N. Galitis, (MMOF, Greece) Prof. Dr. N. Demesticha, (MMOF, Greece) Prof. Dr. E. Hamada, (NEMROCK, Egypt) Prof. Dr. A. Omar, (Alexandria University, Egypt) Prof. Dr. O. Mansour, (NCI, Egypt) Prof. Dr. H. El Ghazaly, (Ain Shams, Egypt) 14:00-14:30 Neoadjuvant systemic therapy in locally advanced breast Prof. Dr. Y. Eralp, (MMOF-Turkey) 14:30-15:00 Chemotherapy of Advanced Breast Cancer Prof. Dr. A. Christopoulou, (MMOF, Greece) 15:00-15:30 Palliative Care equals better quality of life in MBC Prof. Dr. H. Elzawahry, (NCI, Egypt) 15:30-16:00 Discussion on the Barriers as Challenges for Academic Research 13:00-14:00 Lunch 16:00-17:00 CLOSING REMARKS 08:30-16:00 Hall (B) EORTC Lung Cancer meeting (members only)